Incentives & Funding
A Fiscally Responsible Environment for Business
Investing in Next Generation Industries
Ranked as one of the top states for doing business and as the driver of the Southeastern economy, Georgia is widely respected for its comprehensive approach to economic development.
Rowen’s team helps prospective businesses connect with the right local and state resources ensuring they can maximize their impact and potential within our knowledge community and across the state.
Georgia Business Incentives
Take a closer look at tax credits and business incentives available in the state of Georgia.
Statewide Incentives
Local Incentives
Programs for Success
The Latest News from Rowen
Media Coverage
Gwinnett’s bet to build Georgia version of Research Triangle Park starts to pay off
Originally published in The AJC. Belgian biopharmaceutical facility to anchor massive life sciences campus, which still has 1,900 acres to develop. Sometimes envy is the driving force behind economic development. Many states covet the ecosystem created by North Carolina’s Research Triangle Park, a massive biotech and life sciences hub positioned between the Tar Heel State’s […]
Media Coverage
Atlanta’s Suburban Life Sciences Push Gains Traction as UCB Commits $2B to Rowen
Originally published in Globest.com. Rowen, an ambitious project to create a 2,000-acre life sciences park that combines sustainability, environmental protection and advanced manufacturing in a suburban Atlanta county, has scored its first major win. UCB, a global biopharmaceutical company based in Brussels, has announced a $2 billion investment in 79 acres in the Gwinnett County […]
Media Coverage
UCB scoops up 79 acres in Gwinnett County for $2 billion manufacturing plant
Originally published in the Atlanta Business Chronicle. Story Highlights UCB Inc. paid $14.3 million for 79 acres along what used to be known as Old Freeman Mill Road. The Belgium-based pharmaceutical giant plans to develop a $2 billion plant on the Gwinnett County site. It will be part of the planned Rowen life sciences research […]